- REUTERS
Musk memo to Tesla staff: return to office or leave company

FILE PHOTO: Tesla CEO Elon Musk attends the Tesla Shanghai Gigafactory groundbreaking ceremony in Shanghai, China January 7, 2019.
11:14 JST, June 2, 2022
Tesla Inc Chief Executive Elon Musk has asked employees to return to office or leave the company, according to a memo sent to staff that has been circulating on social media.
“Anyone who wishes to do remote work must be in the office for a minimum (and I mean minimum) of 40 hours per week or depart Tesla,” the memo said.
Reuters could not immediately verify the authenticity of the memo. Tesla did not respond to a request for comment. Musk could not be reached for comment.
In response to the memo that was tweeted from an unverified account, the billionaire, who has proposed to take Twitter Inc private in a $44 billion deal, said, “They should pretend to work somewhere else.”
Musk would “review and approve” any cases where they could not meet the minimum, according to the memo.
Tesla joins a wave of companies mandating a return to office for employees. While some big employers have embraced voluntary work-from-home policies permanently, others including Alphabet Inc’s Google are betting that it is best to push in-person interactions among colleagues.
Twitter CEO Parag Agrawal tweeted in March that Twitter offices would be reopening but employees could still work from home if they wanted to.
“Wherever you feel most productive and creative is where you will work and that includes working from home full-time forever,” Agrawal said in a tweet https://bit.ly/3x6oy1e dated March 3.
"NEWS SERVICES" POPULAR ARTICLE
-
Japanese Actor-Director Kitano Says His New Film Explores Homosexual Relations in the Samurai World
-
Japan’s Nikkei Up Sharply as Chip-Related Stocks Rally (Update 1)
-
Japan’s Nikkei Muted; Set to Post First Weekly Drop in Five as Tech Stocks Drag
-
Japan’s Nikkei Pares Early Gains as Investors Lock in Profits
-
Israel Searches for Traces of Hamas in Raid of Key Gaza Hospital Packed with Patients
JN ACCESS RANKING